From the chloroform extract of A
Many protocols explore 200500 mcg daily for 412 weeks, with dosing frequency and duration varying by research context
Recognising these factors is essential for identifying at-risk individuals and implementing appropriate supplementation strategies
Anyone considering IV therapy should undergo screening for conditions like glucose 6 phosphate dehydrogenase (G6PD) deficiency, kidney problems, and iron overload
It is driven by movement patterns, joint mechanics, stability deficits, referred pain, nerve irritation, or inflammatory sensitization
Huemer and colleagues have developed a diagnostic and management pathway for patients with a suspected remethylation disorder and have provided a comparison of the various cobalamin defects associated with hyperhomocysteinemia, the respective enzymatic/incorporations tests available, and the genes involved in these diseases (see Table 4) (101)